Dr. Sara Hafezi Bakhtiari finished her residency in Anatomical Pathology a fellowship in GI/ Liver/ Pancreas at U of T, laboratory medicine program. Currently she is a consultant gastrointestinal/ Pancreas pathologist at the department of Laboratory medicine at Lakeridge Health Oshawa, Durham Cancer Center and an assistant professor of pathology at Laboratory Medicine and Pathobiology Program, University of Toronto School of Medicine as well as a member or Royal College of Physician and Surgeons of Canada and a member of American Board of pathology.
She is involved in educational activities as a member of pathology residency training committee, didactic course planning and teaching for pathology residents, medical and dentistry students at U of T. Her areas of interest include biobanking, digital pathology and AI as well as translational research in study of biomarkers in pre/malignant lesions of gastrointestinal tract. She is currently the physician lead for digital pathology and director of biobank at Lakeridge Health Oshawa and the faculty lead for anatomical pathology at U of T for co-learning quality improvement program.
Through reviewing different sets of slides, the participant would be able to improve their ability to evaluate and differentiate non-neoplastic, pre/ malignant identities in the digestive system and evaluate primary vs metastatic intra and extra luminal lesions as well as get familiar with some of the histologic changes associated with new treatments.
At the end of this session participants will be able to:
Evaluate and identify
Identify some of the changes in GI tract associated with extra luminal diseases.
Identify histologic changes associated with new treatments.